| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.21262 |
| P8608 | Fatcat ID | release_pvgvty3jxra4jhwrj7en22yycu |
| P3181 | OpenCitations bibliographic resource ID | 763607 |
| P698 | PubMed publication ID | 16871574 |
| P5875 | ResearchGate publication ID | 6914009 |
| P50 | author | Fiorella Piemonte | Q39438702 |
| Valerio Nobili | Q56507694 | ||
| P2093 | author name string | Paul Angulo | |
| Donatella Comparcola | |||
| Maria Rita Sartorelli | |||
| Matilde Marcellini | |||
| Rita Devito | |||
| Paolo Ciampalini | |||
| P2860 | cites work | Establishing a standard definition for child overweight and obesity worldwide: international survey | Q24643889 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Liver fibrosis in overweight patients | Q28145482 | ||
| Nonalcoholic fatty liver disease: a feature of the metabolic syndrome | Q28208772 | ||
| Idiopathic steatohepatitis in childhood: a multicenter retrospective study | Q28283720 | ||
| Nonalcoholic Steatohepatitis in Children | Q29013392 | ||
| Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| The natural history of nonalcoholic fatty liver disease: a population-based cohort study | Q29617161 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. | Q34327135 | ||
| Blind and ultrasound-guided percutaneous liver biopsy in children | Q35214076 | ||
| Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease | Q35565097 | ||
| Long term prognosis of fatty liver: risk of chronic liver disease and death. | Q35596463 | ||
| Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population | Q40889441 | ||
| Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. | Q43494872 | ||
| Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. | Q44545460 | ||
| Lowering the criterion for impaired fasting glucose is in order | Q44666297 | ||
| Body fat distribution, relative weight, and liver enzyme levels: a population-based study. | Q44785873 | ||
| The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies | Q45209585 | ||
| Prevalence of and risk factors for fatty liver in a general population of Shanghai, China | Q46591774 | ||
| Histopathology of pediatric nonalcoholic fatty liver disease. | Q46735998 | ||
| Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey | Q46884684 | ||
| Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial | Q47234529 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects | Q71655107 | ||
| American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood | Q73167281 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 458-65 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice | |
| P478 | volume | 44 |
| Q26744488 | A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence |
| Q36966590 | A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD. |
| Q53039947 | Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. |
| Q36071135 | An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis |
| Q36860745 | Anthropometric and metabolic characteristics in children with clinically diagnosed nonalcoholic fatty liver disease. |
| Q26825364 | Antioxidant vitamins in the context of nonalcoholic fatty liver disease in obese children and adolescents |
| Q37039886 | Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach |
| Q37376439 | Caring for adults with pediatric liver disease |
| Q34939164 | Childhood obesity and cardiovascular disease: links and prevention strategies |
| Q30357622 | Clinical advances in pediatric nonalcoholic fatty liver disease. |
| Q45349947 | Clinical and histological features of nonalcoholic fatty liver disease in children |
| Q26859406 | Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening |
| Q37313872 | Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease |
| Q45062198 | Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. |
| Q36952218 | Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease. |
| Q28478084 | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates |
| Q30367203 | Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease |
| Q38249022 | Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease. |
| Q37149656 | Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". |
| Q37385271 | Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery |
| Q33796012 | Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis |
| Q37120909 | Drug metabolism alterations in nonalcoholic fatty liver disease |
| Q37297834 | Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease |
| Q46417024 | Effect of endurance exercise on hepatic lipid content, enzymes, and adiposity in men and women |
| Q51481737 | Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. |
| Q45427615 | Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. |
| Q33718945 | Fatty liver disease in children: eat now pay later. |
| Q37230336 | Fatty liver in children. |
| Q37634334 | Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes. |
| Q62066904 | Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease |
| Q84449591 | Hepatic progenitor cells: Another piece in the nonalcoholic fatty liver disease puzzle |
| Q36095663 | Heritability of nonalcoholic fatty liver disease |
| Q38732493 | Histological Assessment of NAFLD. |
| Q34306736 | Histopathology of nonalcoholic fatty liver disease |
| Q38699261 | Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q34499029 | Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis |
| Q57944356 | How do we care for children with fatty liver disease? |
| Q36848280 | How should we manage patients with non-alcoholic fatty liver disease in 2007? |
| Q62066961 | Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease |
| Q33893011 | Identification and treatment of metabolic complications in pediatric obesity |
| Q51877937 | Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries. |
| Q90679258 | Incidence of cirrhosis in young birth cohorts in Canada from 1997 to 2016: a retrospective population-based study |
| Q36963157 | Increasing Physical Activity Decreases Hepatic Fat and Metabolic Risk Factors |
| Q30453231 | Inflammation in nonalcoholic steatohepatitis |
| Q40598412 | Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment |
| Q37488800 | KASL clinical practice guidelines: management of nonalcoholic fatty liver disease |
| Q36844453 | Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children |
| Q46553519 | Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial |
| Q36946721 | Liver disease among children in Hawai'i diagnosed with metabolic syndrome |
| Q46638698 | Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin |
| Q46779305 | Liver steatosis in obese prepubertal children: a possible role of insulin resistance |
| Q42527743 | Long-term effects of metformin and lifestyle modification on nonalcoholic Fatty liver disease obese adolescents |
| Q36340974 | Long-term interdisciplinary therapy reduces endotoxin level and insulin resistance in obese adolescents |
| Q40425043 | Low Serum Potassium Levels Associated with Disease Severity in Children with Nonalcoholic Fatty Liver Disease |
| Q46845039 | Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis |
| Q92861568 | Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model |
| Q35880997 | Multidisciplinary care of obese children and adolescents for one year reduces ectopic fat content in liver and skeletal muscle |
| Q91666456 | NAFLD in children: new genes, new diagnostic modalities and new drugs |
| Q89927147 | NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology |
| Q37847587 | Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment |
| Q37375539 | Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment |
| Q89216668 | Nonalcoholic fatty liver disease |
| Q33913788 | Nonalcoholic fatty liver disease as a comorbidity of childhood obesity |
| Q51064791 | Nonalcoholic fatty liver disease in severely obese adolescent and adult patients. |
| Q37788538 | Nonalcoholic fatty liver disease: a challenge for pediatricians |
| Q37417603 | Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study |
| Q37215529 | Nutrition and nonalcoholic fatty liver disease in children |
| Q54019499 | Nutrition and nonalcoholic fatty liver disease in children. |
| Q27002523 | Obesity, nutrition, and liver disease in children |
| Q50704509 | Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis. |
| Q51018465 | Over-nutrient environment during both prenatal and postnatal development increases severity of islet injury, hyperglycemia, and metabolic disorders in the offspring. |
| Q34813427 | Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause |
| Q83094715 | Pathology of nonalcoholic fatty liver disease |
| Q37592952 | Pediatric non-alcoholic fatty liver disease: an increasing public health issue. |
| Q38126776 | Pediatric nonalcoholic fatty liver disease |
| Q35171570 | Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk |
| Q34390296 | Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge |
| Q41844897 | Pediatric nonalcoholic fatty liver disease: Overview with emphasis on histology |
| Q37807779 | Pediatric nonalcoholic fatty liver disease: a comprehensive review. |
| Q37976341 | Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. |
| Q49084390 | Physical activity, sedentary time, and liver enzymes in adolescents: the HELENA study |
| Q34085058 | Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network |
| Q62067002 | Portal inflammation as index of steatohepatitis in children with nonalcoholic fatty liver disease |
| Q38195808 | Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition |
| Q37198732 | Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference |
| Q34440962 | Review article: the management of paediatric nonalcoholic fatty liver disease |
| Q38235945 | Role of liver biopsy in nonalcoholic fatty liver disease |
| Q27012812 | Screening for metabolic and reproductive complications in obese children and adolescents |
| Q48152092 | The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups. |
| Q33937046 | The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease |
| Q36792850 | The Progression and Natural History of Pediatric Nonalcoholic Fatty Liver Disease. |
| Q57423553 | The Role of PAI-1 and Adiponectin on the Inflammatory State and Energy Balance in Obese Adolescents with Metabolic Syndrome |
| Q42548519 | The TONIC trial: a step forward in treating pediatric nonalcoholic fatty liver disease |
| Q37863129 | The cytoskeleton in nonalcoholic steatohepatitis: 100 years old but still youthful |
| Q34046719 | The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease |
| Q29617157 | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association |
| Q36918386 | The effect of weight loss on pediatric nonalcoholic Fatty liver disease |
| Q41844517 | The effect of weight reduction on ultrasonographic findings of nonalcoholic Fatty liver. |
| Q37101542 | The efficacy of pharmacological treatment in pediatric nonalcoholic Fatty liver disease |
| Q86404554 | The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease |
| Q34778237 | The metabolic syndrome and nonalcoholic fatty liver disease in children |
| Q37473320 | The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years |
| Q37140026 | The obesity epidemic and nonalcoholic fatty liver disease in children |
| Q33437876 | The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease |
| Q38643266 | The pharmacological management of NAFLD in children and adolescents |
| Q35614956 | The role of metformin in the management of NAFLD |
| Q39646956 | The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease |
| Q27023893 | Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges |
| Q42727018 | Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers |
| Q30248230 | Treatment of nonalcoholic fatty liver disease: role of AMPK. |
| Q27016644 | Type 2 diabetes: etiology and reversibility |
| Q91406319 | Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum |
| Q35119509 | Update on fatty liver disease and steatohepatitis. |
| Q36853567 | Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder |
| Q30431928 | Weight trajectories through infancy and childhood and risk of non-alcoholic fatty liver disease in adolescence: the ALSPAC study. |
| Q84194021 | What's in a NAme? |
Search more.